Rockefeller Capital Management
SLS icon

Rockefeller Capital Management’s SELLAS Life Sciences SLS Stock Holding History

Rockefeller Capital Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.1K Hold
5,000
– – ﹤0.01% 3695
2025
Q4 		$18.9K Hold
5,000
– – ﹤0.01% 3537
2025
Q3 		$8.05K Buy
+5,000
New +$8.91K ﹤0.01% 3733

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Rockefeller Capital Management's SLS Position: Q1 2026 in Review

Rockefeller Capital Management held its SELLAS Life Sciences (SLS) position steady in Q1 2026 at 5,000 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3695.

Rockefeller Capital Management first reported a position in SLS in Q3 2025 and has held it in 3 quarters since. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Rockefeller Capital Management held 5,000 shares of SELLAS Life Sciences worth $21.1K as of Q1 2026.
  • Rockefeller Capital Management left its SELLAS Life Sciences share count unchanged in Q1 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3695 holding.
  • Rockefeller Capital Management first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.